Aspirin Treatment Failure and the Risk of Recurrent Stroke and Death Among Patients with Ischemic Stroke
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 22 (2) , 100-106
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurementsNature Reviews Cardiology, 2009
- Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial StenosisStroke, 2009
- Overestimation of Platelet Aspirin Resistance Detection by Thrombelastograph Platelet Mapping and Validation by Conventional Aggregometry Using Arachidonic Acid StimulationJACC, 2005
- Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?American Heart Journal, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Aspirin response and failure in cerebral infarction.Stroke, 1993
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989